Postprandial renal haemodynamic effect of lixisenatide vs once‐daily insulin‐glulisine in patients with type 2 diabetes on insulin‐glargine: An 8‐week, randomised, open‐label trial

2017 ◽  
Vol 19 (12) ◽  
pp. 1669-1680 ◽  
Author(s):  
Lennart Tonneijck ◽  
Marcel H. A. Muskiet ◽  
Mark M. Smits ◽  
Trynke Hoekstra ◽  
Mark H. H. Kramer ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Glargine ◽  
Haemodynamic Effect ◽  
Open Label ◽  
Once Daily ◽  
Daily Insulin ◽  
Open Label Trial ◽  
Insulin Glulisine

Efficacy of Adding Once-Daily Insulin Glulisine in Japanese Type 2 Diabetes Patients Treated with Insulin Glargine and Sitagliptin

2014 ◽  
Vol 16 (10) ◽  
pp. 633-639 ◽  
Author(s):  
Mitsuyoshi Takahara ◽  
Toshihiko Shiraiwa ◽  
Naoto Katakami ◽  
Taka-aki Matsuoka ◽  
Iichiro Shimomura
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Glargine ◽  
Once Daily ◽  
Daily Insulin ◽  
Insulin Glulisine ◽  
Diabetes Patients

Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine in insulin-naïve subjects with type 2 diabetes (SUSTAIN 4)

2016 ◽  
Vol 120 ◽  
pp. S51 ◽  
Author(s):  
Vanita Aroda ◽  
Stephen Bain ◽  
Bertrand Cariou ◽  
Milivoj Piletic ◽  
Ludger Rose ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Glargine ◽  
Efficacy And Safety ◽  
Once Daily ◽  
Daily Insulin
Sign in / Sign up

Export Citation Format

Share Document